Moore Musings

April spotlight: Crux

Reinventing project finance for energy and manufacturing

Apr 16 • 

Marissa Moore

1

1

The Green Room reflections: Storytelling clarity

What VCs really mean when they say “simplify”

Apr 14 • 

Marissa Moore

March 2025

"Palantir for X" is inevitable, but not enough

In the past, only certain industries placed significant value on having a core knowledge graph – soon every vertical will

Mar 8 • 

Marissa Moore

2

February 2025

The AI-powered codification of tribal knowledge

How vertical AI is reshaping industries

Feb 1 • 

Marissa Moore

1

January 2025

The pulse from the 2025 JPM Healthcare Conference

My unfiltered observations

Jan 15 • 

Marissa Moore

As Led Zeppelin once sang, “Ramble On”…

My unfiltered, stream of consciousness take on an ‘About Me’ page

Jan 9 • 

Marissa Moore

Why I started a deal flow distribution list

And why I’m doubling down

Jan 7 • 

Marissa Moore

December 2024

December spotlight: Kaleidoscope Bio

A spotlight on biotech R&D operations and one company’s approach to improving it

Dec 30, 2024 • 

Marissa Moore

October 2024

Biopharma R&D: Where new tech can help

We see lots of opportunity in AI applied to clinical-stage automation and analytics

Oct 18, 2024 • 

Marissa Moore

September 2024

Biopharma R&D: Macro headwinds loom

Will software be the answer?

Sep 27, 2024 • 

Marissa Moore

Vertical SaaS is on the verge of a massive AI transition...

...but it’ll be guided by experienced hands

Sep 19, 2024 • 

Marissa Moore

The AI impact: Are we seeing a new era of biopharma?

A high-level overview of the market and potential opportunities for AI

Sep 10, 2024 • 

Marissa Moore